Macquarie Group Ltd

Source: SEC Form 13F · as of Mar 2026

Macquarie Group Ltd holds 46 biotech & pharma companies tracked by BioSniper, totaling $1.26B in value as of Mar 2026 (SEC Form 13F).

Companies held

46

Total value held

$1.26B

CompanySharesValue
PMPhilip Morris International Inc981,304$162.2M
GILDGILEAD SCIENCES, INC.1,010,606$140.8M
BMYBRISTOL MYERS SQUIBB CO1,958,745$118.8M
MCKMcKesson Corporation134,595$116.5M
MRKMerck & Co., Inc.870,918$104.8M
LLYELI LILLY & Co103,586$95.3M
JNJJOHNSON & JOHNSON332,443$81.3M
PFEPFIZER INC2,321,799$65.2M
ABBVAbbVie Inc.273,227$59.3M
AMGNAMGEN INC130,388$45.9M
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC.201,623$34.8M
CAHCardinal Health Inc.144,038$30.4M
UNHUnitedHealth Group Incorporated Common Stock (DE)108,606$29.4M
AZNASTRAZENECA PLC120,191$23.7M
ABTABBOTT LABORATORIES192,989$19.8M
VRTXVERTEX PHARMACEUTICALS INC / MA40,236$18.0M
BHCBausch Health Companies Inc.3,250,000$17.6M
GMOptec International, Inc.193,582$14.4M
CORCencora Inc.39,745$12.5M
ELVElevance Health Inc.36,707$10.7M
REGNREGENERON PHARMACEUTICALS, INC.13,050$10.1M
ZTSZoetis Inc.50,192$5.9M
ALNYALNYLAM PHARMACEUTICALS, INC.16,047$5.3M
IDXXIDEXX LABORATORIES INC /DE9,342$5.2M
UTHRUNITED THERAPEUTICS Corp7,905$4.7M
INCYIncyte Corp.39,159$3.7M
IQVIQVIA Holdings Inc.17,845$3.0M
GEHCGE HealthCare Technologies Inc.41,931$3.0M
DGXQuest Diagnostics Incorporated14,170$2.8M
RPRXRoyalty Pharma plc47,022$2.3M
WSTWest Pharmaceutical Services Inc.6,259$1.6M
BIIBBIOGEN INC.8,512$1.6M
NBIXNEUROCRINE BIOSCIENCES INC11,826$1.6M
TEVATeva Pharmaceutical Industries Limited50,339$1.5M
SIGASIGA TECHNOLOGIES INC244,853$1.3M
ZBHZimmer Biomet Holdings Inc.13,488$1.2M
INSMINSMED Inc5,193$849K
VTRSViatris Inc52,706$712K
MRNAModerna, Inc.8,005$407K
RVMDREVOLUTION MEDICINES, INC.3,331$324K
BAXBaxter International Inc.16,976$285K
TECHBIO-TECHNE Corp5,162$270K
DVADaVita Inc.1,100$169K
LEGNLegend Biotech Corp6,096$110K
RCELAvita Medical Inc.11,902$44K
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)324$6K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.